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Acute and long-term effects of isoflurane and sevoflurane
anaesthesia in laboratory mice
Abstract
Isoflurane is to date the most common volatile anaesthetic in laboratory rodents whereas the modern
sevoflurane is usual for inhalation anaesthesia in human medicine. In this study it was aimed to
characterize and compare the clinical properties and safety of both anaesthetics for anaesthetizing mice.
In an approach that mirrors the laboratory routine (spontaneous breathing, gas supply via nose mask,
preventing hypothermia by a warming mat) a 50-minutes anaesthesia was performed. Anaesthetics were
administered at standardized dosages of 1.5 X minimum alveolar concentrations (1.85% for isoflurane,
3.25% for sevoflurane) in 100% oxygen. Induction and recovery from anaesthesia proceeded quickly,
within 1 and 2 minutes respectively. During anaesthesia, all reflex testing were negative and no serious
impairment of vital functions was found; all animals survived. Most prominent side effect during
anaesthesia was the respiratory depression with marked decrease of respiration rate, hypercapnia and
acidosis. Under anaesthesia, heart rate and core body temperature remained stable and within normal
range, but were significantly increased for 12 hours after anaesthesia. Locomotor activity, food and
water consumption and body weight progression showed no abnormalities after anaesthesia. No relevant
differences between the two anaesthetics were found. In conclusion, both anaesthetics equally provide
high safety margin with acceptable side effects and are therefore recommended for anaesthesia in
laboratory mice.
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1. ABSTRACT 
Isoflurane is to date the most common volatile anaesthetic in laboratory rodents 
whereas the modern sevoflurane is usual for inhalation anaesthesia in human medi-
cine. In this study it was aimed to characterize and compare the clinical properties 
and safety of both anaesthetics for anaesthetizing mice. 
In an approach that mirrors the laboratory routine (spontaneous breathing, gas sup-
ply via nose mask, preventing hypothermia by a warming mat) a 50-minutes anaes-
thesia was performed. Anaesthetics were administered at standardized dosages of 
1.5 X minimum alveolar concentrations (1.85% for isoflurane, 3.25% for sevoflurane) 
in 100% oxygen. 
Induction and recovery from anaesthesia proceeded quickly, within 1 and 2 minutes 
respectively. During anaesthesia, all reflex testing were negative and no serious im-
pairment of vital functions was found; all animals survived. Most prominent side effect 
during anaesthesia was the respiratory depression with marked decrease of respira-
tion rate, hypercapnia and acidosis. Under anaesthesia, heart rate and core body 
temperature remained stable and within normal range, but were significantly in-
creased for 12 hours after anaesthesia. Locomotor activity, food and water consump-
tion and body weight progression showed no abnormalities after anaesthesia. No 
relevant differences between the two anaesthetics were found.  
In conclusion, both anaesthetics equally provide high safety margin with acceptable 
side effects and are therefore recommended for anaesthesia in laboratory mice. 
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2. THEORETICAL BACKGROUND AND 
ANAESTHESIA MILE STONES  
2.1. General anaesthesia 
Anaesthesia (from Greek αν-, an-, "without"; and αἲσθησις, aisthēsis, "sensation") is 
defined as the absence or abolition of sensation. This term should be differentiated 
from analgesia which is defined as the absence or abolition of pain. General anaes-
thesia involves rendering a patient unconscious whereas local anaesthesia (or more 
correctly local analgesia) is aimed at blocking conduction of nerves to the operative 
site. In order to provide safe as well as adequate general anaesthesia, the anaesthe-
siologist must combine the need for unconsciousness, the need for analgesia, and 
the need for muscle relaxation to provide the best operative conditions for the sur-
geon. 
There are many ways to design an anaesthetic plan to meet the requirements for 
general anaesthesia: muscle relaxation appropriate for the procedure, unconscious-
ness, and analgesia. Both volatile and injection anaesthetics can meet those re-
quirements. 
Four main stages of general anaesthesia are recognized regardless of the method in 
which the anaesthesia is delivered. These stages are based upon the patient’s body 
movements, respiratory rhythm, oculomotor reflexes, and muscle tone. 
In general, a patient in stage one is conscious and rational, however the perception 
of pain is diminished. Stage one is commonly termed the analgesia stage.  
Stage two, the delirium stage, is marked by the patient becoming unconscious, how-
ever the body responds reflexively and irrationally to stimuli. Breath holding may be 
present and can result in hypoxia, however tone is maintained in pharyngeal muscles 
and a patient can maintain and protect it’s own airway. Pupils generally become di-
lated.  
Stage three, the surgical anaesthesia stage, is characterized by increasing degrees 
of muscular relaxation. Protective pharyngotracheal reflexes are absent and the pa-
tient is unable to protect the airway.  
Stage four is medullary depression. This stage is characterized by cardiovascular 
and respiratory collapse due to depression of the cardiovascular and respiratory cen-
ters in the brain stem. 
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2.2. Types of anaesthesia 
2.2.1. Injection anaesthesia 
In the past, injection anaesthesia has played a major role in work with laboratory ro-
dents. However, it’s use has been confided by several facts, like large differences in 
sensitivity and dosages between species and strains, the fact that it is virtually uncon-
trollable once injected and that very long recovery periods occur in some cases. 
Moreover the recommended dosages for specific species or strains vary considerably 
(up to a factor 10) between different protocols [1], opening a door for various unex-
pected adverse effects, insufficient anaesthesia or high death rates. 
This situation led, in the past years, to a steady increase in the use of inhalation an-
aesthesia in laboratory animal routine [1, 2]. 
2.2.2. Inhalation anaesthesia 
Inhalation anaesthesia refers to the delivery of anaesthetic vapours into the body via 
the respiratory tract and through uptake and distribution, a portion of the anaesthetic 
agent is presented to the nervous system, resulting in the absence of sensation. In-
duction and recovery are quick, depth of anaesthesia is good controllable, and the 
anaesthesia can be adapted to any individual need. Thanks to those characteristics it 
is becoming more and more present in laboratory rodents 
2.3. Minimum alveolar concentration  
The idea of minimum alveolar concentration was introduced  in 1963 by Eger and 
Merkel, who described a technique for establishing a minimal concentration of anaes-
thetic required to prevent gross muscular movement in response to a painful stimulus 
[3]. 
Minimum alveolar concentration is a concept used only for volatile anaesthetics. It is 
the equivalent of effective dose 50 (ED50) for other, non volatile drugs. In simple 
terms, it is defined as the concentration of the vapour in the lungs that is needed to 
prevent movement (motor response) in 50% of subjects in response to a surgical 
(pain) stimulus. This measurement is done at steady state, by providing a constant 
alveolar concentration for 15 minutes, allowing for an equilibration between the gas-
ses in the alveoli, the blood and the brain to take place. It is a clinically useful opera-
tional definition, allowing easy comparisons between the potency of different anaes-
thetic agents and featuring impressive stability [4, 5]. 
Thus, although the term minimum alveolar concentration was used by Eger in the 
original paper, it is actually a median value. 
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2.4. Surgical tolerance 
Unconsciousness, analgesia and blockade of somatic motor response to noxious 
stimulation are the most important goals of general anaesthesia [4]. Volatile anaes-
thetics such as isoflurane, sevoflurane and halotane are frequently used in modern 
clinical and laboratory practice, to provide hypnosis (unconsciousness) and a loss of 
responses to noxious-evoked stimuli (immobility). 
Surgical tolerance is a term that refers to a depth of anaesthesia reached when the 
subject does not react with a motor response to a noxious stimulus in form of a skin 
incision. 
By providing anaesthetics at concentrations of 1.5 X minimum alveolar concentration, 
it is generally postulated, that 99.9% of animals do not react to painful stimuli [6, 7], 
i.e. that they have reached surgical tolerance. 
2.5. Volatile anaesthetics 
The volatile anaesthetics are a class of general anaesthetic drugs. Most of them 
share the property of being liquid at room temperature, but evaporating easily for 
administration by inhalation (e.g. halothane, isoflurane, sevoflurane). The funda-
mental mechanisms by which these inhalational agents induce anaesthesia are simi-
lar, although not completely understood [8].  
There are quite a few inhalant anaesthetics available for use in human and veterinary 
medicine (nitrus oxide, halothane, enflurane, desflurane etc.). However, confined by 
frames of this work, only the two agents used in our study will be presented below.  
2.5.1. Isoflurane 
 
 
Figure 1  Chemical structure of isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane) [9]. 
 
 
Isoflurane (2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane) is a halogenated ether 
used for inhalational anaesthesia (Figure 1). Its use in human medicine has declined 
during the last decade, being replaced mainly with sevoflurane, desflurane and the 
intravenous anaesthetic propofol. Nevertheless isoflurane is still frequently used for 
veterinary anaesthesia especially in horses, dogs and cats [10].  
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It has low blood-gas partition coefficient (Table 1), which enables quick induction and 
recovery abilities. It is virtually not metabolized (metabolic rate around 0.2%) [10], 
and it is reported to have weak analgesic effect in humans. 
2.5.2. Sevoflurane 
 
 
Figure 2  Chemical structure of sevoflurane (2,2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl 
ether) [9]. 
 
 
Sevoflurane (2,2,2-trifluoro-1-[trifluoromethyl]ethyl fluoromethyl ether), also called 
fluoromethyl hexafluoroisopropyl ether, is a sweet-smelling, non-flammable, highly 
fluorinated methyl isopropyl ether used for induction and maintenance of general an-
aesthesia (Figure 2). 
Like isoflurane, sevoflurane has a low blood-gas partition coefficient (Table 1), but 
the fact that is less irritant to mucosa and that it has some analgesic effect made it 
very common in human medicine. It is still rarely used in veterinary practice. 
 
 Sevoflurane Isoflurane 
Molecular weight 200.005 g/mol 184.5 g/mol 
Boiling point (at 1 atm.): 58.6 °C 48.5 °C 
Density: 1.517–1.522 g/mL 1.496 g/mL 
MAC (Human) : 2 vol % 1.15 vol % 
Vapor pressure (at 20°C): 157 mmHg (20.9 kPa) 238 mmHg (31.7 kPa) 
Vapor pressure (at 25°C): 197 mmHg (26.3 kPa) 295 mmHg (39.3 kPa) 
Vapor pressure (at 35°C): 317 mmHg (42.3 kPa) 450 mmHG (60.0 kPa) 
Blood:Gas partition coefficient: 0.68 1.4 
Oil:Gas partition coefficient: 47 98 
 
Table 1  Overview of physical characteristics of the two volatile anaesthetics.  
 
2.6. Unwanted effects of anaesthesia 
The ideal anaesthetic agent would produce reversible unconsciousness, analgesia  
and muscle relaxation, with no effect on other physiological functions. Unfortunately, 
no anaesthetic drug meets this standard and they all affect other body systems to 
some extent. The most serious side effect of anaesthetic drugs is depression of res-
piration and the cardiovascular system. There are two reasons why these side effects 
are important:  
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1) They occur at "therapeutic" doses, i.e. there is significant depression at the doses 
of anaesthetic needed to produce anaesthesia.  
2) Severe depression of either respiration or the cardiovascular system is life-
threatening. 
Although the pharmacodynamic effects of anaesthetics vary, the mechanisms by 
which they cause anaesthesia emergencies are usually the same: excessive hy-
potension, bradycardia, arrhythmias, myocardial depression, vasodilatation or vaso-
constriction, hypoventilation followed by hypoxemia [11]. 
2.6.1. Effects on respiration and acid-base homeostasis 
By depressing respiratory centres in the brain stem, all anaesthetic agents show ad-
verse effects upon respiration. Diminished respiration rate or tidal volume, together 
with arrhythmic breathing or even apnoe episodes, are very common during anaes-
thesia and have obvious and detrimental effects on oxygen (O2) tissue supply as well 
as on subsequent carbon dioxide (CO2) elimination. 
Arterial blood gas analysis is the gold standard for assessing respiratory function. 
The gas exchange capability of the lung can be directly measured. The three main 
measurements (partial pressure of oxygen (pO2), partial pressure of carbon dioxyde 
(pCO2) and pH) made by the blood gas analyzer are used together to obtain a de-
tailed picture of the state of respiratory system [11]. 
2.6.1.1. Partial pressure of carbon dioxide 
It is a measure of ventilatory status of the patient and normally ranges between 35 
mmHg and 45 mmHg in most mammalian species. In mice these values are slightly 
lower and average around 25 mmHg [1]. 
Hypercapnia (increase in pCO2) may be caused by hypoventilation or by dead space 
rebreathing [11].  
2.6.1.2. Partial pressure of oxygen 
The pO2 is a measure of the oxygenating efficiency of the lungs. The pO2 measures 
the tension of oxygen dissolved in physical solution in the blood plasma, irrespective 
of the haemoglobin concentration. Haemoglobin saturation measures the percentage 
saturation of haemoglobin with oxygen and is related to the pO2 by a sigmoid curve 
[12].  
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2.6.1.3. Acid-base homeostasis 
The pH of the body must be maintained within a narrow range. Most body systems 
function optimally at intracellular pH of near 7.4. As the pH changes (either higher or 
lower), enzymes may cease to function, nerve and muscle activity weakens, and fi-
nally all metabolic activity becomes deranged. 
2.6.1.4. Carbonic acid-bicarbonate buffering 
The carbonic acid bicarbonate system is a classic chemical buffer. In addition, the 
body has the ability to eliminate chemicals from either end of the chemical reaction to 
maintain the pH. In the case of bicarbonate, the chemical reaction is 
H+    +    HCO3-    ↔    H2CO3    ↔    H2O    +    CO2 
This buffering system is very effective because of the ability to convert carbonic acid 
to carbon dioxide (through the enzyme carbonic anhydrase) then remove CO2 from 
the body through respiration. For example, adding enough acid to lower the serum 
bicarbonate by half would normally drop the pH from 7.4 to 6.0, but instead all the ex-
tra H2CO3 is removed by conversion to CO2. The drop in pH stimulates extra respira-
tions so CO2 (and subsequently more H2CO3) is removed. The pH therefore falls only 
to 7.3 or 7.2. 
On the other side of the equation, excess acid or excess alkali can be removed 
through the kidneys. 
Changes in carbonic acid concentration occur rapidly (within seconds) in response to 
hypo- or hyperventilation. On the other hand, changes in bicarbonate require hours 
or days through the relatively slow process of elimination by the kidney. 
The ratio of bicarbonate to carbonic acid determines the pH of the blood. Normally 
the ratio is about 20 parts bicarbonate to 1 part carbonic acid. 
This relationship is described in the Henderson-Hasselbach equation: 
pH = pK + log (HCO3-/H2CO3) 
Thereby, pK is the dissociation constant of the buffer and is 6.10 at body tempera-
ture. The change in pK with temperature is the reason why pH determinations must 
be adjusted for patients with abnormal temperatures. 
2.6.1.5. Respiratory acidosis 
Build-up of carbon dioxide occurs when ventilation is inadequate. This is usually due 
to absence of adequate respiratory effort such as when central control of respiration 
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is depressed due to anaesthetics, narcotics or barbiturates. When respiration ceases 
due to cardiac arrest, of course, respiratory acidosis is an immediate result. 
Respiratory acidosis can also result when obstruction of air motion leads to carbon 
dioxide build-up [12]. 
2.6.1.6. Compensation of respiratory acidosis 
Whereas respiratory changes can occur within seconds or minutes, metabolic 
changes take hours to days. Compensation for respiratory acidosis must occur 
through elimination of acid through the kidney. Only in chronic respiratory problems, 
such as severe obstructive airway disease, will compensation be seen. 
2.6.2. Effects on cardio-vascular system 
Anaesthetic agents usually have impact on the function of heart and circulation. Pe-
ripheral vasodilatation and decrease of heart rate, cardiac output, and blood pressure 
are such adverse effects of anaesthesia which can lead to hypotension, possible 
heart arrest and finally death of the animal [13]. Mild hypotension is mostly tolerated 
by healthy animals but prolonged serious hypotension (mean arterial pressure <60 
mmHg) produces renal shutdown. From this, the animal can go into renal failure and 
may die after anaesthesia. Therefore, it is mandatory to control the impairment of 
heart functions and circulation during anaesthesia to prevent irreversible harm or 
sudden death during and after an anaesthesia.   
2.6.3. Effects on body temperature regulation 
General anaesthetics interfere with temperature regulation both by depressing the 
hypothalamic centres and by suppressing heat generation mechanisms such as 
shivering. This adverse effect of anaesthesia falls in weight by laboratory rodents 
even more than in other species. Small rodents, because of their relatively low body 
mass, have a high body surface area-to-mass ratio. This high ratio combined with 
suppressed thermoregulatory mechanisms allows for rapid escape of body heat in 
small rodents and consequently they are highly susceptible to hypothermia during 
anaesthetic events [14]. Small mammals can experience a decrease of 4-10°C in 
core body temperature during only 15-20 min of general anaesthesia, resulting in 
marked hypothermia [14, 15].  
Mild to moderate hypothermia does not kill animals but leads to other problems, the 
most important being cardiac arrhythmias, increased susceptibility to infection, pro-
longed anaesthetic recovery time, and decreased minimum alveolar concentration 
values for inhalant anaesthetics, resulting in increased potential for anaesthetic toxic-
ity [14, 16].  
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In order to control body temperature and maintain it at the normal level we need to 
have a means of measuring temperature and correcting it (e.g. heating blankets, in-
sulation etc.) if necessary. 
2.7. Monitoring during anaesthesia and post-
anaesthetic recovery 
The purpose of anaesthesia is to provide a reversible status of hypnosis, muscle re-
laxation, analgesia, and diminished reflexes while the adverse effects and the overall 
risk for the patient are minimized. When we consider the main side effects of anaes-
thesia (hypothermia, cardiovascular and respiratory depression) the argument for 
monitoring becomes very compelling. In the research community, even more than in 
the clinic, the question of post-anaesthetic recovery falls in weight. The complexity of 
surgical or otherwise painful experimental procedures and the impact on research 
results make monitoring to a vital part of not only anaesthesia but also of scientific 
work itself. Moreover, from the view of animal welfare, it is an obligation to control 
laboratory animals after interventions in order to detect and treat any disease or im-
pairment of their well-being.  
However, in mice, the majority of classical monitoring systems are hardly applicable 
in the laboratory routine. One reason is, that many commercially available devices 
are not useful in such a small mammal, even when the mouse lays in anaesthesia 
(e.g. the normal heart rate values of up to 800 beats per minute in the mouse cannot 
be measured with common ECG devices, pulse oximetry sensors are to big to be 
placed on the mouse vessels). For the monitoring during the recovery phase, when 
the mouse is conscious and moves around, the measuring procedure would greatly 
influence animal’s physiological parameters through restraint (e.g. ECG monitoring) 
or constant handling and manipulation (e.g. indirect blood pressure measurements).  
2.8. Telemetry  
Handling and restraining methods, especially those applicable for work with labora-
tory rodents, induce stress and influence basic physiological parameters. Those 
stimuli are so strong that they are actually used as models for the investigation of 
sympathetic and adrenomedullary systems [17, 18]. The responses catalogued to 
these stressors include changes in heart rate, blood pressure, blood flow, nociceptive 
threshold, as well as increases in plasma catecholamines, adrenocorticotropic hor-
mone, prolactin, and corticosterone. 
This situation has inspired the search for new technologies that would enable the 
monitoring of physiological parameters in freely moving animals while stress factors 
and artefacts caused by handling and immobilization are avoided. Telemetry repre-
sents a widely used in vivo technique in mice and other species for monitoring body 
temperature, heart rate, blood pressure and other variables in unrestrained animals. 
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Telemetric measuring eliminates the need for tethers that connect the animal with the 
data acquisition equipment. It also allows continuous data collection without disturb-
ing the animal, and thereby presumably generating data that are not confounded by 
animal manipulation and associated physiologic effects [19-22].  
The most common commercially available telemetry system is provided by Data Sci-
ences International, St. Paul, MN, USA. This system is composed of implantable te-
lemetry transmitters, receiver plates, receiver multiplexor or matrix which enables the 
use of up to 16 receivers simultaneously and a computer equipped with Dataquest 
PCI card for digitalizing and storing data for subsequent analysis. 
The implantable transmitter suitable for use in small laboratory rodents (weight 3.6 
grams, length 21.0 mm, width  9.1 mm, depth 11.4 mm, volume 1.9 cc) consists of a 
small cylindrical body with two coiled wires protruding from one end of the cylinder 
(Figure 4). The transmitter body contains an amplifier, a battery, radio-frequency 
electronics, and a magnetically activated switch which allows the device to be turned 
on and off. The surface of the transmitter body is covered with a silastic material, to 
prevent irritation of the visceral organs and subsequent inflammation and adhesions. 
The leads consist of flexible helically wound stainless-steel wires of 0.6 mm diameter. 
They are insulated with a silicone tube, which is red coloured for the positive and 
white coloured for the negative lead led (see also Figure 4).  
In order to obtain a positive deflection from the analogue output of the receiver, it is 
recommended by the manufacturer, that the negative lead is positioned approxi-
mately at the right shoulder and the positive lead towards the lower left chest (Figure 
3) [23, 24]. 
The transmitter passes the data to a receiver located beneath the animals’ cage via a 
radio signal. The receiver transforms this into a digital signal. Digital information from 
the telemetry receiver is relayed to the data acquisition system via a multiplexer (ana-
logue ECG adaptor) (Figure 8). The data acquisition system converts the raw data 
into an electrocardiogram and the numerical results of heart rate, core body tempera-
ture and locomotor activity counts. Finally, all data are stored on the hard disk of the 
computer for subsequent analysis.  
 
Nikola Cesarovic, 2009  13 
 
 
Figure 3 Radiograph showing location of the implanted telemetry transmitter. The body of the 
transmitter was positioned in the abdominal cavity. The positive lead was formed to a 
wire loop and fixed to the xiphoid process with sutures. The negative one was tunnelled 
subcutaneously from  thorax to the neck and fixed  as a wire loop between the muscles 
right and ventral of the trachea [25].  
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3. PROBLEM DESCRIPTION 
3.1. Mouse anaesthesia: state of the art 
Anaesthesia in rodents is common by injection of hypnotic, analgesic and muscle re-
laxant agents [2]. Since continuous intravenous, target-controlled infusion or the so 
called total intravenous anaesthesia with short acting drugs as propofol [26] is hardly 
to master in mice, the intraperitoneal or subcutaneous application route is normally 
chosen in this species [1, 27, 28]. It seems easy and practical, to induce general an-
aesthesia with a single injection of long-acting drugs (e.g. pentobarbital) or mixtures 
(e.g. ketamine/xylazine, medetomidine/midazolam/fentanyl), however, this type of 
anaesthesia is hardly controllable. Once the initial dose has been administered, the 
duration and depth of anaesthesia cannot be adjusted to the specifics (strain, age, 
gender, daytime, housing conditions, etc.) and individual reactions that influence the 
animals’ response on the anaesthetic. Thus, despite previous dosage testing, the 
safety margin of injection anaesthesia regimens remains often narrow, i.e. anaesthe-
sia is shallow in some individuals or the death rate can be unexpectedly high [1, 27, 
29].  
Such failures are rarely found with inhalation anaesthesia. The commercially avail-
able, modern volatile anaesthetics as isoflurane, sevoflurane, desflurane and others 
are vaporized in dedicated vaporizers and added to a carrier gas which is supplied to 
the animal via the respiratory tract. Due to their low blood:gas partition coefficients, 
they provide rapid induction of anaesthesia, are short-acting, and are removed in 
short time from the body, greatly by respiration [30, 31]. The dosage can be adapted 
easily and prompt to the individual animals’ response. Thus, provided, that the ani-
mals vital functions and depth of anaesthesia are monitored, cases of death are un-
usual, because the course of anaesthesia is easy controllable and recovery seems 
fast. Due to their safety, recent volatile anaesthetics are increasingly used in labora-
tory rodents [2, 32], especially since ready to use inhalation anaesthesia devices, 
which are tailored for small rodents, are commercially available. The up to date an-
aesthesia equipments [33-35] normally include active systems for preventing the re-
lease of waste gas which is mandatory for protecting the personnel and which has 
been a problem in the past [36-38].  
The most common and well-known volatile anaesthetic in laboratory rodents is isoflu-
rane [2]. Sevoflurane, which is a more modern inhalation anaesthetic used primarily 
in human medicine [39] is less common in veterinary medicine due to its higher costs. 
Sevoflurane is suggested to have a weaker irritant action on the mucous membranes 
of the respiratory tract in man than isoflurane [40]. This common assumption was not 
confirmed by an investigation in rabbits, where it was found, that sevoflurane induced 
similar aversive behaviours of struggling and breath-holding as isoflurane when it 
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was used for the induction of anaesthesia by mask inhalation [41]. However, in rats 
and mice sevoflurane has been shown to induce less aversion than isoflurane [42].  
From the other end, the possible action mode [43] and effects as neuroprotection [44] 
and cardioprotection [45] of these widely used inhalation anaesthetics are currently 
reported. However, the clinical impact of isoflurane and sevoflurane is described so 
far mostly in man or in animal species other than mice [46].  
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4. AIM OF THE STUDY 
The continously increasing number of mice used in biomedical research, as well as 
development of complex surgical models and transgenic technologies, has brought 
anaesthesia in laboratory rodents under the spot light in the research community. Not 
only the questions of safety and feasibility, but also the changes of physiological pa-
rameters during anaesthesia and in the recovery phase fall in focus. 
The goal of this study was to investigate possible advantageous properties and 
drawbacks of isoflurane and sevoflurane anaesthesia in laboratory mice. In a practi-
cal setting, the substances were compared by their effects during anaesthesia and in 
the post-anaesthetic recovery period from a clinical view, with the aim, to determine 
their impact on animal physiology and post-anaesthetic general condition in the labo-
ratory routine. This will serve guidance for monitoring these types of anaesthesia and 
provide insight in their safety and in effects, which might interfere with results and 
aims of underlying biomedical experiments in laboratory mice.  
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5. MATERIALS AND METHODS 
5.1. Animals and housing conditions 
Sixty-four female C57BL/6J mice were obtained at the age of 6 weeks from our in-
house breeding colony. The mice were free of all viral, bacterial, and parasitic patho-
gens listed in FELASA recommendations [47]. Their health status was monitored by 
a sentinel program throughout the experiments.  
Animals were kept in type 3 open-top plastic cages (425 mm x 266 mm x 150 mm, 
floor area 820 cm2) with autoclaved dust-free wooden bedding (80–90 g/cage).  
Autoclaved hay (8–12 g/cage) and 2 nestlets (each 5 x 5 cm), consisting of cotton 
fibres (Indulab, Gams Switzerland) were provided as nesting materials. A standard 
cardbox house (Ketchum Mainufacturing Inc., Brockville, Canada) served as shelter. 
Animals were fed a pelleted mouse diet (Kliba No. 3431, Provimi Kliba, Kaiseraugst, 
Switzerland) ad libitum and had unrestricted access to sterilized drinking water. The 
light/dark cycle in the room consisted of 12/12 h with artificial light (approx. 40 Lux in 
the cage) from 03.00 a.m. to 03.00 p.m. The temperature was 21±1°C, with a relative 
humidity of 50±5%, and with 15 complete changes of filtered air per hour (HEPA H 14 
filter); the air pressure was controlled at 50 Pa.  
Mice were housed in groups, except the 4 days before and 4 days after anaesthesia, 
where they were individually housed. The first day of single housing served for adap-
tation on the change of housing conditions; from the second day onwards the indi-
viduals’ normal values for heart rate, core body temperature, locomotor activity, body 
weight, food and water consumption were taken. To avoid interfering influences, all 
necessary husbandry and management procedures were completed in the room be-
fore starting with single housing of mice and disturbances (e.g. visitors or unrelated 
experimental procedures) were not allowed. The animal room was insulated to pre-
vent electronic noise.  
The study was approved by the Cantonal Veterinary Office (Zurich, Switzerland) un-
der the license number 111/2007. Housing and experimental procedures were in ac-
cordance with the Swiss animal protection law and conform to the European Conven-
tion for the protection of vertebrate animals used for experimental and other scientific 
purposes (Council of Europe nr.123 Strasbourg 1985). 
5.2. Preliminary transmitter implantation 
Prior to the anaesthesia experiments, sixteen mice were instrumented at the age of 
ten weeks with telemetric transmitters. TA10ETA-F20 transmitters (Data Sciences 
International, St. Paul, MN, USA) able to measure heart rate, core body temperature 
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and locomotor activity in freely moving mice were implanted using the method estab-
lished and described previously [23].  
The day prior to the surgical implantation of the transmitter, a general health check 
was performed in these animals. Mice were weighted to ensure that none of the ani-
mals weight less than 20 grams, which in our experience represents the critical value 
for successful operation. Then, the hair from the belly and neck area was removed 
using a shearing machine. 
The preparation of the telemetric transmitter and its implantation were carried out un-
der aseptic conditions. On the day of implantation, firstly, the telemetric transmitters 
were removed from their sterile package. The leads were shortened and the sensory 
portions were prepared by removing the tubing and fixing the wires with silk sutures 
(6-0 Perma-Handseide, Ethicon, Norderstedt, Germany) to loops (Figure 4).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4 Picture of a TA10ETA-F20 implantable telemetry transmitter which collects heart rate, 
core body temperature and locomotor activity in the freely moving mouse. The sensing 
portions of the leads are free of silicone tubing and are formed to loops, which improves 
effectiveness and reliability of the signals as described previously [23]. The positive lead 
is indicated by the red coloured tubing whereas the white lead is the negative electrode.  
 
Then, the mice were anesthetized by inhalation of the volatile anaesthetic sevoflu-
rane (Sevorane™, Abbott, Baar, Switzerland) at a concentration of 3–8% in 100% 
oxygen at a flow rate of 400 ml/min. The anaesthetic gas was administered with a 
Sensoring portion of the 
leads, formed to a loop
Transmitter body
Insulated portion of the 
leads
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nose mask. Ketamine (Ketasol-100™, Dr. Graub, Bern, Switzerland) was injected 
subcutaneously as pre-medication at a dosage of 45 mg/kg body weight as pre-
emptive analgesia. To ensure maintenance of the core body temperature in physio-
logical boundaries, mice laid in dorsal recumbence on a liquid-driven warming table 
set on 39 ± 1°C in the laminar flow of a work bench. 
The skin of the neck and the belly was disinfected with iodine solution (Betadine, 
Mundipharma, Basel, Switzerland). A 1-1.5 cm long incision in the skin from the lower 
thorax to the abdomen along the midline was made. The negative lead was tunnelled 
subcutaneously from the thorax to the neck, where a small incision (0.5 cm) was 
made. The skin and underlying muscles were bluntly prepared to make place for the 
fixation of the wire loop. The electrode was fixed between the muscles located to the 
right of the trachea, using two silk sutures (6-0 Perma-Handseide, Ethicon, Nor-
derstedt, Germany). The wound in the neck was closed then with absorbable sutures 
(6-0 Vicryl, Ethicon, Norderstedt, Germany) in layers. Then, the abdominal wall was 
opened and the telemetric transmitter body was implanted into the abdominal cavity 
of the mouse. The positive electrode was sutured to the xiphoid process with silk su-
tures (Figure 5). Finally, the muscle layers and the skin at the abdominal region were 
closed with absorbable sutures. 
 
 
 
 
 
 
 
 
 
 
Figure 5  Localisation of the TA10ETA-F20 transmitter and position of the leads in the mouse. 
Such position is required to obtain a positive deflection on ECG with amplitudes large 
enough for subsequent analysis. A: The transmitter body is implanted in abdominal cav-
ity. B: The negative lead is positioned between the muscles in the right neck area. C: The 
positive lead is fixed at the xyphoid. 
 
B
C
A
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Postoperative pain was treated with buprenorphine (Temgesic ™, Reckitt and Col-
man Products Ltd., Hull, England), at a dose of 0.1 mg/kg body weight, injected sub-
cutaneously twice per day for 4 days. Animals were monitored daily for 10 days after 
the surgery for appearance, posture, spontaneous moving behaviour, body weight, 
and food and water consumption. After transmitter implantation, the mice had a pe-
riod of 6 weeks convalescence until the start of the first anaesthesia experiment 
5.3. General experimental setting 
All experiments were conducted when the mice were aged 16--36 weeks, with body 
weights ranging from 24 to 30 g. To avoid any influence of circadian rhythm, all ex-
periments and weighing procedures were carried out between 03.00 and 06.00 p.m.. 
Anaesthesia was performed in a separated operating area within the animal room to 
avoid transportation of the animals while ensuring stable conditions of humidity, air 
pressure and room temperature as well as air conditioning with sufficient extraction of 
gases and smells.  
Anaesthesia was provided by a commercially available rodent inhalation anaesthesia 
apparatus (Provet, Lyssach, Switzerland), which was equipped with interchangeable 
vaporizers for isoflurane (Ohmeda Isotec 5, Abbott, Baar, Switzerland) and sevoflu-
rane (Ohmeda Sevotec 5, Abbott, Baar, Switzerland). Waste anaesthetic gas was 
eliminated by a pump-driven filter system. As carrier gas, 100% oxygen was used in 
a flow rate of 400 mL/minute. The concentrations of anaesthetic gases in the induc-
tion chamber and nose mask were measured using a sidestream monitoring device 
which employs infrared technology (Datex-Ohmeda AS/3, Anandic Medical, Deissen-
hofen, Switzerland). The device was calibrated just before use using the proprietary 
standard reference gas of the producer company. 
5.4. Determination of minimum alveolar concentra-
tion 
Forty-eight, non-transmitter-implanted mice underwent anaesthesia 2-3 times in or-
der to standardize anaesthesia by establishing minimum alveolar concentration. Care 
was taken that animals had a break of at least two weeks between the tests. Mini-
mum alveolar concentration was determined with a protocol which was a modification 
of published methods [48-50].  
Briefly, after inducing anaesthesia in the chamber for two minutes at maximum con-
centration of anaesthetic gases (5% and 8% for isoflurane and sevoflurane respec-
tively), the mouse was taken out of the chamber and placed in dorsal recumbence on 
a liquid-driven warmed mat set on 39°C±1°C. Then, the anaesthetic gas was applied 
at defined concentration via a nose mask. After an equilibration time of 10 minutes, 
every 5 minutes during a total of 30 minutes, painful stimuli in form of pinching the 
tail, the toe or the interdigital webbing, the abdominal skin, and neck skin were ap-
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plied. The reactions were evaluated as positive motor reaction or negative motor re-
action to painful stimuli depending on whether the animal responded with any kind of 
movement.  
Using this protocol, firstly rough estimation was done, within the concentration win-
dow (1%-3% and 2%-4% for isoflurane and sevoflurane respectively) in which we 
have empirically expected the values for minimum alveolar concentration to lay. Con-
centrations were graded in 0.25% steps and 10 animals per concentration were used. 
Finally, 2 concentrations were picked, the lowest one at which 95% of animals had as 
negative and the highest one at which 95% had as positive evaluated motor reac-
tions. Twenty-five animals per concentration were put through as verification of those 
concentrations being partial pressures bracketing the response or lack of response in 
our tested population. Minimum alveolar concentration was then calculated as a 
mean between the two.  
5.5. Acid-base and blood gas analysis 
Non-transmitter-implanted mice were used at 3-4 weeks after minimum alveolar con-
centration determination experiments, for obtaining arterial blood with the goal to as-
sess the side effects of the anesthetics used on respiration and acid-base balance. 
Arterial blood was taken under anesthesia at time points 10, 30, and 50 minutes of 
anaesthesia from 8 mice per anaesthetic and time point. Following incision of the an-
terior neck, the right common carotid artery was dissected. Using a fine-bladed pair 
of scissors, a small hole was cut in the artery and the arterial blood was collected in a 
heparinised syringe. Values for pH, pCO2, and HCO3 were determined immediately 
using a blood gas analyzer (AVL Compact 3, AVL List, Graz, Austria). The animals 
were euthanized immediately by cervical dislocation, before they could die from the 
subsequent rapid loss of blood under anaesthesia.  
The normal values of pH, pCO2, and HCO3 used for comparison had been previously 
established from the arterial blood of 20 mice of similar age as those used in the pre-
sent study [1].  
5.6. Anaesthesia characterisation experiments 
Anaesthesia was induced by setting the mouse in a clear perspex induction chamber 
(8x8x8 cm, volume 512 ml) in which then either 5% isoflurane (Isoflo™, Abbot, Baar, 
Switzerland) or 8% sevoflurane, carried by 400ml/min of pure oxygen, was intro-
duced (Figure 6). Animals were observed for their behaviour to detect signs of excita-
tion or distress due to the exposition to the anaesthetic atmosphere (e.g. trials to es-
cape, breath holding, eye blinking, nose scratching, struggling). Mice lost the righting 
reflex in approximately one minute.  
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Figure 6 C57BL/6J mouse during induction. The chamber is placed on the water-driven warming 
mat. 
 
 
After 2 minutes, the animal was quickly transferred to a nose mask, where anaesthe-
sia was maintained with 2.8% isoflurane or 4.9% sevoflurane, equivalent to 1.5 X 
minimum alveolar concentration (the establishing of those values is described 
above). Mice were breathing spontaneously while they were laying in dorsal recum-
bence on a water-driven warming mat (Gaymar, TP500, Orchard Park, NY) set on 
39°C±1°C to ensure constant body temperature (Figure 7).  
 
 
 
Figure 7  Maintenance of anaesthesia with the nose mask. The mouse lay in dorsal recumbence 
on the warming mat for the whole time of anaesthesia.  
 
 
The tail pinch, pedal withdrawal and abdominal skin pinch reflexes were proven to be 
negative in 5-minutes intervals and the respiratory rate was counted from the move-
ment of the thorax wall.  
Anaesthesia was stopped after 50 minutes by removing the nose from the mask and 
let the mouse breath room air. Two to three minutes later, when the mice had righted 
themselves from dorsal to ventral recumbence and were able to move, they were set 
back in their home cage. 
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5.6.1. Telemetric data acquisition and analysis 
From sixteen transmitter-implanted mice, telemetric data were recorded in 8 mice per 
anaesthetic. Mice were allocated to groups in random order. Telemetric data were 
recorded with the Dataquest LabPRO program. Data collection was initiated by 
switching on the transmitter with a magnet. Data acquisition started 3 days before 
anaesthesia and continued for 4 days following the experiment. After data analysis 
was performed, all raw data were archived on institutes own server (ltkdco3-178-
130).  
For estimating acute effects of anesthesia (i.e. measuring data during the 50-minutes 
anaesthesia  experiment), heart rate and core body temperature were recorded for 4 
seconds every 15 seconds (four measuring points of 4 seconds per minute) while 
administering anesthesia. From these data, the mean values of heart rate and core 
body temperature were calculated for each minute in the individual. Normal values 
represent means from the time period 03.00-06.00 p.m. from three days prior to the 
experiment. 
For investigating the post-anaesthetic effects of anaesthesia, heart rate and core 
body temperature were measured every 5 minutes for 30 seconds and 10 seconds, 
respectively. Locomotor activity was recorded continuously and stored at 5 minute 
intervals. Individuals’ normal values were established by calculating the means from 
the three days prior to anaesthesia. 
For the analysis of the long-term, post-anaesthetic effects, it was considered that 
values vary greatly during a 24h-cycle since mice are active mainly during the night. 
Therefore, the means of the telemetric values of an animal were calculated sepa-
rately for the night and day phase. The difference between the night (12 h dark 
phase) and day (12 h light phase) values was calculated and compared to the indi-
viduals’ normal values. This determination of circadian rhythms (delta night-day) of 
heart rate, core body temperature, and locomotor activity was adapted from an ear-
lier description [51].  
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Figure 8 Schematic drawing of the telemetry acquisition system. The mouse is equipped with the 
transmitter, which measures the data and passes them via radio signals to the receiver 
plate. The receiver plate is located underneath the animal’s cage. RMX 10 is a matrix 
which on the one hand provides power to the receivers and on the other multiplexes a 
number of signals into one that could be stored on the computer via the BCM 100 (Data-
quest PCI card). 
 
 
 
5.7. Monitoring of body weight, food and water con-
sumption 
The body weight progression and the daily food and water consumption were estab-
lished from transmitter-implanted mice for 3 days before and 3 days after anaesthe-
sia. Weights (animal, food pellets, water bottle) were recorded with a precision bal-
ance (PR 2003 Delta Range, Mettler-Toledo AG, Greifensee, Switzerland), especially 
adjusted for use with moving animals. Body weights recorded in transmitter-bearing 
mice were corrected to take into account the weight of the transmitter (3.6 g). The 
mean normal weights (from 3 consecutive daily measurements prior to the experi-
ment) were calculated for each mouse, and compared to the weights recorded on 
each of the 3 days afterwards.  
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5.8. Statistical analysis 
All data are presented as means with standard deviation. For statistical analysis, the 
program SPSS for Windows, version 13.0 was used. Heart rate, core body tempera-
ture and locomotor activity data were tested for normal distribution (Kolmogov - 
Smirnof test) and homogeneity of the variance (Levene’s test). After passing these 
tests, a one way ANOVA was performed to compare group means of heart rate, core 
body temperature, locomotor activity and pH, HCO3, pCO2. Additionally, for the long-
term telemetric results, post hoc comparison with Bonferroni tests was performed at 
each of the 4 days after anaesthesia with the corresponding normal values. P-values 
≤0.05 were considered significant. 
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6. RESULTS 
6.1. Minimum alveolar concentration 
Using the methods previously described, we found 1.85 % and 3.25% to be the 
minimum alveolar concentration values for isoflurane and sevoflurane respectively in 
adult female C57BL/6 mice that we used in our experiments.   
By providing anaesthetics in concentration of 1.5 X minimum alveolar concentration it 
is generally postulated, that 99.9% of animals do not react to painful stimuli [6, 7], i.e. 
that they should have reached surgical tolerance. Thus, all consecutive anaesthesia 
experiments were conducted with 2.8% isoflurane or 4.9% sevoflurane. 
At this place it should be pointed out that minimum alveolar concentration values de-
pend not only on age, sex and strain of the mice used but also on atmospheric pres-
sure and temperature. Thus those values represent our laboratory specific results 
and should be taken more as guidelines rather than as absolute benchmarks. 
6.2. Acute effects of anaesthesia 
After animals were placed in the induction chamber (Figure 6) and exposed to the 
anaesthetic gas, they moved around but did not show any behaviour that would hint 
on excitation or distress. In particular, no obvious signs that would indicate irritancy 
from the anaesthetic atmosphere on the mucous membranes of the eye and the res-
piratory tract were observed (e.g., trials to escape, breath holding, eye blinking, nose 
scratching, struggling). All mice were immobilised, i.e. showed clear loss of righting 
reflex, within 1 minute after the anaesthetic has been introduced into the induction 
chamber.  
Telemetric recordings revealed that putting the mouse in the induction chamber, re-
sulted in tachycardia with 737.5±19.7 bpm for isoflurane and 750.7±22.4 bpm for the 
sevoflurane group (Figure 10). Normal values were established to be 523.0±39.4 
bpm for the respective day time. 
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Figure 10 Heart rate during induction of anaesthesia with isoflurane and sevoflurane, n=10. Statistical 
analysis showed no difference between the treatments.  
 
 
Analysis of heart rate during induction has also shown that approximately 100 sec 
after the introduction of the anaesthetic, the heart rate have reached the level at 
which it stayed stable during the whole time (50 minutes) of the anaesthesia. This 
was similar to the normal values obtained at the adequate day time in conscious mice 
before the experiment. Statistical comparison of the heart rate during the 120-
seconds induction period showed no differences between the two treatment groups 
(Figure 10).   
After induction, the mice were transferred on to the warming mat and the anaesthesia 
was maintained via a nose mask (Figure 7). Monitoring of heart rate, core body tem-
perature and respiratory rate was maintained during 50 minutes of anaesthesia. 
Heart rate and core body temperature remained stable within the physiological 
boundaries. The respiratory rate was markedly decreased with 40.9±6.4 breaths/min 
and 44.4±5.8 breaths/min for isoflurane and sevoflurane respectively (mean of the 
50-minutes anaesthesia). Thus, the respiratory rate was substantially below the nor-
mal values of the conscious mouse which was 150-170 breaths/min (Figure 11,12). 
The lowest respiratory rate was observed after 2 minutes of induction, when it aver-
aged 31.7±2.7 breaths per minute for isoflurane and 30.6±4.6 breaths per minute for 
the sevoflurane treated group respectively. Highest respiratory rates were noted after 
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10 minutes of anaesthesia with 54±7.8 and 50±9.7 breaths per minute for isoflurane 
and sevoflurane respectively (Figure 11). 
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Figure 11  Respiratory rate during 50 minutes of anaesthesia with isoflurane or sevoflurane. Anaes-
thesia was induced in an induction chamber (time point 0-3 minutes) and was maintained 
via a nose mask (time point 5-50 minutes). Mice were breathing spontaneously. The res-
piratory rate was monitored by counting the movement of the thorax wall. Values were 
obtained and noted every 5 minutes. Mean values of 8 mice per group were depicted with 
bars representing standard deviations. 
 
 
Acid-base balance and blood gas measurements revealed hypercapnia and subse-
quent respiratory acidosis at 10 to 50 minutes of anaesthesia (Figure 13). Already 
after 10 minutes, the pCO2 was increased. That trend continued during the subse-
quent measuring points, resulting in strongly increased pCO2 values (58.8±19.4 
mmHg and 61.2±6.5 mmHg for isoflurane and sevoflurane respectively) after 50 min-
utes (Figure 13).Without being able to compensate in such a short time, pH slid into 
acidosis  with 7.15±0.1 and 7.18±0.03 for isoflurane and sevoflurane respectively. 
Statistical comparison of isoflurane and sevoflurane regarding all short term effects 
revealed no significant difference between both anaesthetics.  
When anaesthesia was completed, animals showed increasing breath rate and mus-
cle turgor. Within one minute, they turned in ventral position and moved at 1-2 min-
utes after anaesthesia was finished.  
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Figure 12  Heart rate, core body temperature and respiratory rate during 50 minutes of anaesthesia 
with isoflurane or sevoflurane. Anaesthesia was induced for 2 minutes in an induction 
chamber and then maintained with a nose mask. Animals breathed spontaneously while 
laying on a water-driven warming mat (39°C) to preserve core body temperature. The 
grey areas indicate range of normal values at the corresponding day time, when animals 
are conscious while mostly resting. Mean values of 8 mice are shown with bars repre-
senting standard deviation.  
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Figure 13 Analysis of acid-base balance (pH), partial pressure of carbon dioxide (pCO2), and stan-
dard bicarbonate (HCO3) in arterial blood show acidosis and hypercapnia. Hatched areas 
indicate range of normal values established in a previous study [1]. Mean values of 8 
mice with bars for standard deviation are depicted. ANOVA revealed no difference be-
tween the impact of isoflurane and sevoflurane at any time point during anaesthesia. 
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6.3. Long term effects of anaesthesia 
After animals awoke from anaesthesia, telemetric measurements of 8 mice in each 
group, over 4 days were performed. All animals served as their own control: delta 
values expressing the deviation from normal values established prior to anaesthesia 
were calculated for every individual and each parameter.  
Mean delta values for heart rate and core body temperature showed significant 
(ANOVA; p ≤0.05) increases during the first 12-hours daylight phase after anaesthe-
sia. Mean delta heart rate reached values as high as 55.3±31.9 bpm over normal in 
isoflurane and 81.4±26.1 bpm over normal in the sevoflurane treated group. The in-
crease in core body temperature were 0.6±0.36 °C and 0.5±0.18 °C for isoflurane 
and sevoflurane respectively (Figure 14).  
Locomotor activity was slightly increased, but statistical analysis revealed no signifi-
cant differences in comparison to normal (Figure 14). 
Over the following period up to 4 days after the anaesthesia experiment, the telemet-
ric recordings showed no statistically significant difference in none of the parameters 
measured in this study (Figure 14). 
Body weight, food and water consumption were not changed at 1-3 days after anaes-
thesia (Figure 15).  
Statistical comparison of isoflurane and sevoflurane regarding long-term effects re-
vealed no difference between the two anaesthetics.  
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Figure 14 Long-term measurements of the impact of isoflurane and sevoflurane anaesthesia on 
heart rate, core body temperature and locomotor activity. Delta values represent the de-
viation from normal values (established prior to anaesthesia) at the corresponding 12-
hours day and night time. The mean from 8 mice is depicted, with bars indicating stan-
dard deviation. Compared to normal levels, an elevation of heart rate and core body tem-
perature was relevant at 12 hours after anaesthesia (ANOVA; * p ≤ 0.05). No significant 
differences were found between the effects of isoflurane and sevoflurane. 
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Figure 15  The percentage deviation (delta) from normal values of body weight, and food and water 
intake showed no relevant aberrations. Bars represent standard deviation.  
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7. DISCUSSION 
In an easy to manage standard inhalation anaesthesia procedure, both volatile an-
aesthetics showed a high safety margin and short induction and recovery times. Par-
ticularly the induction of anaesthesia went smoothly without signs of excitation or ei-
ther form of distress. During anaesthesia, the most prominent adverse effect was 
respiratory depression which hints to the respiration rate as a key indicator for moni-
toring and controlling depth of anaesthesia and thus preventing fatal outcome under 
routine conditions. Hypothermia, which usually occurs under anaesthesia, was suc-
cessfully prevented by placing the animal on a warmed mat. After completion of an-
aesthesia, aberrations of physiological functions as elevated heart rate and core body 
temperature remained for approximately half a day. Thus, the post-anaesthetic im-
pact of these inhalation anaesthesia methods is suggested to be of relatively short 
term relevance. Both anaesthetics showed almost identical properties and side ef-
fects, thus none could be proposed as superior over the other.  
Before the investigations started the anaesthesia procedure and dosage of anaes-
thetics were standardized based on the specifics of the equipment (e.g., calibrating 
the gas concentration) and mouse population (e.g., strain, age, gender) used. Depth 
of anaesthesia was predetermined by establishing the minimum alveolar concentra-
tion with the aim to calculate the exact dosage for each anaesthetic, with which an-
aesthesia would be deep enough to allow surgical or otherwise painful interventions.  
The minimum alveolar concentrations were established following the widely known 
method which is a tail pinch at that concentration of anaesthetic gas at which 50% of 
the animals respond with purposeful movements. In addition, we tested several re-
flexes in parallel to the tail pinch to find out, which other stimuli might be useful - or 
even more reliable than tail pinch - for defining the depth of anaesthesia.  From the 
various stimuli, the pedal withdrawal reflex was found to correlate well with the tail 
pinch and other obvious signs of the different anaesthetic stages (e.g. presence or 
absence of spontaneous movements, vocalisation, muscle turgor and bodily tension). 
Altogether, the minimum alveolar concentrations were in the range described before 
for sevoflurane in outbred mice [52] and for isoflurane in C57BL/6J mice [4, 50].  
Based on the preliminary testing, the anaesthetics were compared with dosages of 
isoflurane and sevoflurane that represented 1.5 minimum alveolar concentrations. 
For this dosage it is generally postulated, that 99.9% of animals do not react to pain-
ful stimuli [6, 7], i.e. that the animals have reached surgical tolerance. However, since 
analgesia was not proved with sophisticated methods as the measurements of the 
reaction of heart rate, blood pressure or respiration on a substantially painful stimulus 
(e.g. skin incision) surgical tolerance could not be claimed absolutely from our study.  
Nikola Cesarovic, 2009  35 
However, with our regimens, all animals reached the desired stage of anaesthesia 
and none died, from which we conclude that the method was reliable and safety was 
high.  
In the early induction phase of anaesthesia, heart rate peaked to the upper normal 
level of 700-800 bpm, which we suggest as a normal reaction on removing the animal 
from its cage and putting it in a foreign environment. During anaesthesia, heart rate 
ranged stable within the normal values of the resting mouse (490-550 bpm). This was 
according to data shown for isoflurane anaesthesia, that hint to only slight depression 
of heart and circulation resulting in intact hemodynamic conditions [32, 53-55]. Note-
worthy, the cardiac depression from isoflurane was also less pronounced when com-
pared directly with injection anaesthesia regimens [56, 57], which let the authors con-
clude that isoflurane is superior over injectable anaesthetics in those biomedical re-
search studies, that focus on microcirculation or hemodynamic measures.  
During anaesthesia, core body temperature was maintained with a simple, water-bath 
driven warming mat. The fall of core body temperature due to any kind of anaesthe-
sia is well-known, e.g. a drop to 30-31°C was shown from isoflurane anaesthesia in 
mice [55]. Obviously, such hypothermia should be prevented, because it influences 
physiology and the course of anaesthesia and can finally lead to the dead of the ani-
mal. Thus, warming the animal in long-term anaesthesia with isoflurane is common 
practice since years and particularly worthwhile in mice because they are sensitive to 
hypothermia due to their small size and high body surface [54, 58, 59]. Thus, the 
warming was incorporated in our protocol and is advisable for safety reasons.  
In contrast to the almost normal levels of heart rate and core body temperature, res-
piratory depression (Figure 12), documented by decreased respiration rates (far be-
low the values of the resting mouse) (Figure 11), marked hypercapnia and acidosis 
are shown in equal grades from isoflurane as well as from sevoflurane anaesthesia 
(Figure 13). Hypercapnia and acidosis from isoflurane were also found by others [32], 
but were less intense when compared with injection anaesthesia with pentobarbital 
[57]. Respiration rate was also found to be markedly decreased from isoflurane by 
other studies, but was not as low reported from the literature as we have found it in 
both anaesthetics [58, 59].  
Compared to other widely used protocols of laboratory mouse anaesthesia [1] isoflu-
rane and sevoflurane provided a safe method of general anaesthesia (death rate 0), 
with virtually neglectable side effects upon heart rate and core body temperature. 
However, severe respiratory depression, caused by those two volatile anaesthetics, 
falls even more in weight when compared to results obtained from studies with injec-
tion anaesthesia (Figure 16). 
In summary, respiratory depression was the major adverse effect in both isoflurane 
and sevoflurane (Figure 11, Figure 12) and might be the most probable emergency 
case to be observed when using this type of anaesthesia. From our opinion, it is rec-
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ommended to monitor respiration rate closely when using inhalation anaesthesia. 
The respiration rate could hint on the depth of anaesthesia and could be useful, for 
adapting the dosing of the anaesthetic.  
Time for induction and recovery were almost equal in both anaesthetics (1-2 min-
utes). As an advantage compared to injection anaesthesia, the short recovery time 
from both inhalational anaesthetics must be underscored. The fast recovery makes 
post-operative intensive care (e.g. after long-term anaesthesia or major surgery) 
much easier to manage because it allows detailed planning of work schedules and is 
less personnel intensive.  
By using the telemetric technology, we could continuously collect real-time data over 
some days after anaesthesia without disturbing the animal. Thus, we managed to 
produce results that are not confounded by stress due to handling or restraining the 
animal. Therefore the results represent the actual impact of agents tested upon 
physiological homeostasis of laboratory mice. From this, we found a significant in-
crease of heart rate and core body temperature for 12 hours after the animals had 
recovered from anaesthesia (Figure 14). Locomotor activity showed only a tendency 
to increase in the first hours after anaesthesia, indicating, that physical activity might 
be not the reason for the elevation of heart rate and core body temperature. Also it is 
remarkable, that other behavioural indices as food and water intake were not influ-
enced by both anaesthetics (Figure 15), implying, that a 50-minutes inhalation anaes-
thesia with either isoflurane or sevoflurane are not impairing the overall well-being of 
laboratory mice. 
Comparing isoflurane with sevoflurane, we found no relevant differences between 
both anaesthetics regarding their effects. Whereas several publications describe the 
usefulness of isoflurane, there is limited description of sevoflurane in mice in the lit-
erature. Henke and co-authors compared the induction and recovery times and respi-
ration rate of sevoflurane with isoflurane in the gerbil, ending in the result, that there 
is no preference for one of the two volatile anaesthetics. They found prolonged re-
covery from isoflurane compared to sevoflurane and underlined warming of the ani-
mal as essential to prevent fatal hypothermia during inhalation anaesthesia [58]. An-
other study compared the blood glucose and some specific parameters required in 
functional PET investigations; they estimated sevoflurane superior over isoflurane 
and consequently recommended sevoflurane for physiologic imaging [60]. Others 
compared isoflurane with injection anaesthesia regimens in measures of blood glu-
cose and found both anaesthetic regimens equally useful for performing the elec-
troretinogram in mice [29]. Thus it is concluded that the side effects of both volatile 
anaesthetics, that may influence the outcome of a certain experiment must be de-
fined under the specific experimental conditions and demands.  
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Figure 16 Comparison of injection anaesthesia vs. inhalation anaesthesia regarding their effects on 
heart rate, core body temperature and respiratory rate. Values for injection anaesthesia 
(protocol 1–4) were obtained from a previously published study [1]. Values for inhalation 
anaesthesia (protocol 5 and 6) represent data obtained from the present study. Grey 
background area represent range of normal values for conscious resting mice during cor-
responding day time. 
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In summary, we conducted inhalation anaesthesia in a routine, cost-effective setting, 
i.e. with the use of commercially available equipments as a simple anaesthesia ma-
chine with waste gas scavenge and a warming mat for preventing hypothermia. An-
aesthesia was induced in an induction chamber and maintained with the mouse 
spontaneously breathing in a nose mask. As an alternative, it would be possible to 
perform the induction by restraining the mouse by the scruff of its neck and putting its 
nose in the mask. Thus, the mouse is – to our experience - immobilised within 10-20 
seconds (own data, not shown). For checking the stage of anaesthesia, the tail pinch 
and pedal withdrawal reflexes are useful. Furthermore, the respiration rate might be 
helpful in monitoring the depth of anaesthesia and adjusting the dosage of anaesthet-
ics to the individual needs of each animal during the progression of anaesthesia. 
Since respiratory depression was the most relevant side effect of anaesthesia, this 
adverse effect would be probably the reason if emergency cases (e.g. gasping, ap-
noea) or death occur. To avoid such fatal outcome, we suppose it advisable to take 
care, that the respiration rate is constant and will not drop below a certain level (e.g., 
30 breaths per minute).  
In conclusion, the described anaesthesia procedures would be feasible - or could be 
easily modified – to provide anaesthesia for a wide range of frequently used investi-
gations and interventions in the laboratory routine. We performed an anaesthesia of 
50 minutes duration, however, the time frame might be shortened or extended as de-
sired. By use of such regimens, isoflurane and sevoflurane both provide a safe and 
reliable anaesthesia with short and smooth induction and recovery phases and rela-
tively short acting, easy controllable side effects.  
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